NDC 70381-121-01 - Deep Relief Acne (Blemish) Treatment

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70381-121
Requested NDC
70381-121-01
Package NDCs from labels
70381-121-01, 70381-121-02
Manufacturer
Murad, LLC | Thibiant International, Inc.
Effective date
2022-02-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Deep Relief Acne (Blemish) TreatmentMurad, LLC | Thibiant International, Inc.2022-02-23HUMAN OTC DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70381-121-022022-07-29C16284748780-1e4f33bdf-b1c2-d8a0-e053-dadaa90a6e4eDeep Relief Acne (Blemish) Treatment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70381-121-01Deep Relief Acne (Blemish) Treatment30 mL in 1 BOTTLESOLUTION301
70381-121-02Deep Relief Acne (Blemish) Treatment1 in 1 CARTONSOLUTION11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70381-121DEEP RELIEF ACNE (BLEMISH) TREATMENT (SALICYLIC ACID) SOLUTION [MURAD, LLC]1Legacy NDC, 2 package rows20220609_aa7416db-4b9e-42a5-8a17-3704231333d3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 146 of 146 · 2,901 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SKIN MEDICA Purifying Foaming WashSALICYLIC ACIDAllergan, Inc.064d9e2b-077f-4229-b653-666fc5479ae22013-03-01WarningsExact identifier
unii: O414PZ4LPZ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.